Allen D C, Fon L J, McAleer J J, Irwin S T
Histopathology laboratory, Belfast City Hospital.
Ulster Med J. 1999 May;68(1):17-21.
The study group comprised 13 patients (mean age 68 years) with clinically fixed and biopsy proven moderately differentiated rectal adenocarcinoma (8 high rectal, 5 low-mid rectal) who received synchronous courses of preoperative combination chemotherapy and pelvic radiotherapy (radiotherapy alone in 3 cases) over a period of 8-20 weeks prior to surgical resection. All cases showed varying degrees of mural and mesorectal fibrosis. Three cases did not differ otherwise from usual rectal adenocarcinoma while 4 had a 20-30% diminution in expected tumour area. In 6 cases tumour could not be definitely identified grossly--1 showed a 50% reduction in tumour bulk while 5 had only residual microscopic foci from 0.6-4 mm in maximum dimensions. Only 3 cases had involvement of the mesorectal circumferential radial margin. Four involved lymph nodes in 2 cases were partially hyalinised and calcified. Preoperative combination adjuvant therapy can produce marked regressive morphological changes in rectal adenocarcinoma. The implications of this are discussed.
研究组包括13例患者(平均年龄68岁),患有临床确诊且经活检证实的中度分化直肠腺癌(高位直肠8例,中低位直肠5例),在手术切除前8至20周接受了术前联合化疗和盆腔放疗同步疗程(3例仅接受放疗)。所有病例均显示出不同程度的肠壁和直肠系膜纤维化。3例与普通直肠腺癌无异,而4例预期肿瘤面积缩小了20 - 30%。6例肉眼无法明确识别肿瘤——1例肿瘤体积缩小50%,5例仅残留最大直径0.6 - 4毫米的微小病灶。仅3例累及直肠系膜环周切缘。2例中有4个受累淋巴结部分玻璃样变和钙化。术前联合辅助治疗可使直肠腺癌产生明显的退行性形态学改变。对此的影响进行了讨论。